Free Trial
Want deep insights into your competitors & competitive landscape? Try Patsnap Eureka!

Top 20 Startups & Unicorns companies in Intermittent claudication
by Most News Heat in the United States in 2021

The Intermittent claudication top 20 is Discovery PatSnap’ annual ranking of the top 20 Most News Heat Intermittent claudication Startups & Unicorns in the United States. Discovery has identified the top key players, startups & unicorns, fast-growings, news entrants in 2021, ranking from differnt perspectives, including patent filing intensity, academic research capability, news media heat. The company list is generated from various data types.
Intermittent claudication (Latin: claudicatio intermittens), is a symptom that describes muscle pain on mild exertion (ache, cramp, numbness or sense of fatigue), classically in the calf muscle, which occurs during exercise, such as walking, and is relieved by a short period of rest. It is classically associated with early-stage peripheral artery disease, and can progress to critical limb ischemia unless treated or risk factors are modified.
#
Company Name
Region
Tech Topics
Total
1
Medicine,Pharmacy and Therapeutics,Amyloidosis,
...[+2]
news: 1
2
AddUp SAS
news: 1
3
Medicine,Health care,Pharmacy and Therapeutics
news: 1
4
Biology,Health care,Cardiovascular agent,
...[+2]
news: 1
5
Carrum Health, Inc.
Health care,Systems design,Hospitality industry,
...[+1]
news: 1
6
news: 1
7
Helix
Personal genomics,Big data,Health care,
...[+2]
news: 1
8
Biofourmis Singapore Pte Ltd.
news: 1
9
Medical equipment,Catheter,Health care,
...[+2]
news: 1
10
Aspire Health Science LLC
news: 1
11
news: 1
12
news: 1
13
Molecular diagnostics,Biology,Health care,
...[+2]
news: 1
14
news: 1
15
news: 1
16
news: 1
17
news: 1
18
Integrin,Health care,Pharmacy and Therapeutics,
...[+2]
news: 1
19
G3 Pharmaceuticals, Inc.
Biopharmaceutical,Cardiovascular agent,Drug synthesis,
...[+2]
news: 1
20
EmboMedics, Inc.
Medical equipment,Embolization,Health care,
...[+2]
news: 1
Page generation time: Jul 23 2025